Company: REVB
Filing Date: 2025-05-20
Form Type: S-1
Source: 0001213900-25-045828
Chunk: 226

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-20
Form: S-1
Chunk 226
---
002shares of its common stock and Class G Common Stock Warrants exercisable for 381,004shares of its common stock (see Note 9). The warrant inducement was considered a private placement pursuant to Section 4(a)(2) of the Securities Act. In connection with the warrant inducement, the Company agreed to pay Roth a cash fee of $ 325,000for its services, in addition to reimbursement for certain expenses. The Company received net cash proceeds of approximately $ 3.7million and issuance costs of $ 0.4million. The shares of common stock issued from the exercise of the Class E Common Stock Warrants were registered on Form S-3, which was declared effective by the SEC on September 12, 2024. The Class F Common Stock Warrants and Class G Common Stock Warrants offered in the private placement were registered on Form S-3, which was declared effective on December 20, 2024. 6. Preferred Stock The Company is authorized under its articles of incorporation, as amended, up to 5,000,000shares of preferred stock, which may be issued as designated by the Board of Directors without stockholder approval. As of March 31, 2025, there were noshares of preferred stock issued and outstanding. F-35

7. Common Stock

The Company is authorized under its articles of
incorporation, as amended, to issue up to shares of common stock, par value $ per share.

Common Stock Issuance during the year ended December 31, 2024

On January 29, 2024, the Company issued shares
of common stock for alternative cashless exercises of Class C Common Stock Warrants.

On August 22, 2024, the Company issued shares
of common stock for a cash exercise of Class D Common Stock Warrants for which the Company received total net cash proceeds of $ million.

During 2024 the Company issued a total of
shares of its common stock in connection with multiple financings for which the Company received total net cash proceeds of $ million.

Common Stock Issuance during the three months ended March 31, 2025

Between January 17, 2025 and March 31, 2025 the
Company issued shares of common stock for alternative cashless exercises of Class F Common Stock Warrants.

On February 11, 2025, the Company issued
shares of common stock for RSA grants to employees and directors.

As of March